-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Jan 29, 16:01Prev. Close
204.00
Open Price
206.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 29, 15:59Prev. Close
203.99
Open Price
204.39
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
202.15 (793)
| Cash Flow of Viyash Scientific (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 30.37 | 5.53 | 2.74 | 9.07 | 5.42 | |
| Net CashFlow From Operating Activities | 29.74 | 10.64 | 0.05 | 2.40 | 7.16 | |
| Net Cash Used In Investing Activities | -29.80 | -29.05 | -36.10 | -8.08 | -2.50 | |
| Net Cash Used From Financing Activities | 7.10 | 18.38 | 34.21 | 9.47 | -5.45 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 7.04 | -0.04 | -1.84 | 3.80 | -0.80 | |
| Cash And Cash Equivalents Begin of Year | 5.42 | 4.01 | 5.85 | 2.05 | 2.85 | |
| Cash And Cash Equivalents End Of Year | 12.47 | 3.98 | 4.01 | 5.85 | 2.05 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y
